Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04720976
Title JAB-3312 Activity in Adult Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Jacobio Pharmaceuticals Co., Ltd.
Indications

Advanced Solid Tumor

Therapies

JAB-3312 + Pembrolizumab

Binimetinib + JAB-3312

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.